申请人:Ashikawa Masanori
公开号:US20120108581A1
公开(公告)日:2012-05-03
The present invention provides a low molecular weight compound having EPO production-promoting action and/or hemoglobin production-promoting action. The present invention relates to a fused piperidine compound represented by the following general formula (1):
(wherein, ring A represents a C
10-14
aryl group or 5- to 10-membered heterocyclic group, X represents N—R
7
, a sulfur atom or an oxygen atom, R
1
, R
2
, R
2′
, R
3
and R
3′
independently represent a hydrogen atom, C
1-6
alkyl group or C
3-6
cycloalkyl group, and R
4
, R
5
and R
6
independently represent a hydrogen atom or halogen atom), or a salt thereof, or a solvate thereof.
本发明提供了一种低分子量化合物,具有促进EPO产生和/或促进血红蛋白产生的作用。本发明涉及一种融合哌啶化合物,其表示为以下通式(1):
(其中,环A表示C10-14芳基或5-至10元杂环基,X表示N-R7,硫原子或氧原子,R1、R2、R2'、R3和R3'独立地表示氢原子、C1-6烷基或C3-6环烷基,而R4、R5和R6独立地表示氢原子或卤素原子),或其盐或溶剂化物。